Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-13 Purchase | 2024-03-15 4:15 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 450,000 | $10 | $4,500,000 | 10,179,505 (Indirect) | View |
| 2024-01-31 Purchase | 2024-02-02 4:32 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 5,206,074 | $2.31 | $12,026,031 | 9,729,505 (Indirect) | View |
| 2023-08-29 Purchase(A) | 2023-08-31 11:26 am | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 881,000 | $0.0187 | $16,475 | 30,272,724 (Indirect Direct) | View |
| 2023-08-29 Purchase | 2023-08-29 6:39 pm | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 881,000 | $0.0187 | $16,475 | 43,807,874 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-13 Option Award | 2024-03-15 4:15 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 450,000 | $10 | 10,179,505 (Indirect) | View |
| 2024-02-29 Option Award | 2024-03-04 7:53 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Grayson Paul A. Director | 135,000 | $0 | 381,252 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 6:02 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Charych Deborah H. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 6:01 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Jenkins Annalisa Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:04 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:24 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:23 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:20 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:19 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer | 100,000 | $0 | 176,833 (Direct) | View |
| 2024-02-29 Option Award(A) | 2024-03-04 06:15 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 100,000 | $0 | 284,738 (Direct) | View |
| 2024-02-29 Option Award(A) | 2024-03-04 06:13 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 225,000 | $0 | 522,006 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-01 6:42 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 100,000 | $0 | 285,738 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-01 6:24 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 225,000 | $0 | 522,006 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:35 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 5,206,074 | $2.31 | 9,729,505 (Indirect) | View |
| 2023-11-06 Option Award | 2023-11-06 8:32 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:30 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Charych Deborah H. Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 160,262 | $0 | 231,174 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 215,856 | $0 | 327,605 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Grayson Paul A. Director | 173,721 | $0 | 246,252 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-08-23 Acquisition(A) | 2023-08-31 11:26 am | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 9,000 | $0.0118 | 30,272,724 (Direct) | View |
| 2023-08-25 Option Award(A) | 2023-08-31 11:26 am | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 22,530,460 | $0 | 30,272,724 (Direct) | View |
| 2023-08-28 Acquisition(A) | 2023-08-31 11:26 am | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 110,000 | $0.0171 | 30,272,724 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 9:36 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 7:25 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Grayson Paul A. Director | 18,132,596 | $0 | 18,132,596 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 6:53 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 16,727,648 | $0 | 17,727,648 (Direct) | View |
| 2023-08-23 Acquisition | 2023-08-29 6:39 pm | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 9,000 | $0.0118 | 43,807,874 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 6:39 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 22,530,460 | $0 | 43,807,874 (Direct) | View |
| 2023-08-28 Acquisition | 2023-08-29 6:39 pm | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 110,000 | $0.0171 | 43,807,874 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 6:22 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 6:21 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 6:17 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 6:02 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Charych Deborah H. Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
Ownership | 2023-08-28 4:18 pm | N/A N/A | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 0 | $0 | 1,557,205,277 (Indirect) | View |
Ownership | 2023-08-28 4:16 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Versant Ventures III LLC Versant Venture Capital III L.P. Versant Side Fund III L.P. 10% Owner | 0 | $0 | 632,737,156 (Indirect) | View |
| 2023-08-18 Option Award | 2023-08-22 5:21 pm | 2023-08-18 2033-08-18 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 704,509,037 | $0 | 443,296,919 (Indirect) | View |
| 2023-08-18 Option Award | 2023-08-22 5:21 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 852,696,240 | $0.0103 | 443,296,919 (Indirect) | View |